Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Califf Supports Changing Combo Product Pathway; FDA Developing Proposal

This article was originally published in The Tan Sheet

Executive Summary

FDA concepts for a new pathway could be ready for congressional scrutiny within a year, commissioner nominee Robert Califf says during his confirmation hearing.

Advertisement

Related Content

Senate Bill Aims At Streamlining Combination Product Regulation
Combo Product Reforms Are A Priority For Next User Fee Round, FDA Officials Say
Podcast: FDA's Califf Talks About Combo Product Reform, Commish Prospects
FDA Staying The Course Under Ostroff; Hamburg’s Concerns Will Remain Focus
Ball In Judge’s Court In Combination Product Classification Suit
Combination Products Offer Regulatory Option For Novel Switches

Topics

Advertisement
UsernamePublicRestriction

Register

PS108037

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel